Patents
Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033)
08/1999
08/17/1999US5939570 Estrenes for inducing hypothalamic effects
08/17/1999US5939409 Processes for the production of anti-inflammatory steroids
07/1999
07/28/1999EP0931047A1 Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
07/28/1999CN1224429A Androstene derivs.
07/21/1999EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES
07/20/1999US5925774 Estrenes for inducing hypothalamic effects
07/06/1999US5919957 For the preparation of oxoetiocholenic acid
07/01/1999WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension
06/1999
06/23/1999EP0924219A2 Novel estrenes for inducing hypothalamic effects
05/1999
05/27/1999WO1999025359A1 New composition of matter
05/26/1999EP0917534A2 6,7-oxygenated steroids and uses related thereto
05/14/1999WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life
05/12/1999EP0914165A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
05/06/1999EP0589034B1 Method for making 3-alpha-hydroxy,3-beta-substituted-pregnanes
04/1999
04/07/1999EP0570454B1 Novel steroids
04/06/1999US5892069 Estrogenic compounds as anti-mitotic agents
03/1999
03/24/1999EP0902789A1 Androstene derivatives
03/16/1999US5883087 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
02/1999
02/24/1999CN1209135A Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives
02/03/1999CN1041939C Androstenones
01/1999
01/28/1999WO1999003503A1 The use of angiostatic steroids in photodynamic therapy
01/28/1999CA2296558A1 The use of angiostatic steroids in photodynamic therapy of ocular neovascularization
01/26/1999US5864022 Forming a leaving group in the 3-position, glycosylation of hydroxy groups displacement with azido and reduction to provide 3-amino group
01/14/1999WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life
12/1998
12/30/1998EP0766690A4 Process for the manufacture of 3-amino-substituted glycosylated bile acids
12/15/1998US5849889 Oligosaccharide-containing 14 aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
12/10/1998WO1998055498A1 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS
12/10/1998CA2289524A1 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
12/09/1998CN1041054C Method for preparing medicine composition containing steroid 5-alpha-reductase inhibitors
12/08/1998US5846976 Androstenone derivative
12/01/1998US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
12/01/1998US5843931 6,7-modified 11β-aryl-4-oestrenes
11/1998
11/11/1998EP0876392A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
10/1998
10/28/1998EP0674651B1 Substituted 6-azaandrostenones
10/08/1998WO1998018429A3 A method for lowering plasma levels of lipoprotein(a)
09/1998
09/09/1998EP0863149A1 Process for introducing an amino group on the 14-position of a steroid nucleus
09/02/1998EP0783512A4 Novel androstanes for inducing hypothalamic effects
09/01/1998US5801165 Antiinflammatory, immunosuppressive and antialleric 16, 17-alkylidioxy-steroids
08/1998
08/18/1998US5795870 Steroid ring with amine group side chains
07/1998
07/30/1998WO1998032718A1 New fatty acid derivatives
07/21/1998US5783571 Method of altering hypothalamic function by nasal administration of estrene steroids
06/1998
06/30/1998US5773432 Using certain 17-difluoromethylene-estratrienes in the treatment and prevention of premature occlusive arterial disease
06/23/1998US5770748 20-alkanoyloxy-pregnadiene-3-one-21-nitrile intermediates foroxoetiocholenic acid
06/23/1998US5770592 Vision defects
05/1998
05/20/1998CN1182091A Fluoric steroid 5Alpha-reductase inhibitor and its synthesis process and use
05/07/1998WO1998018429A2 A method for lowering plasma levels of lipoprotein(a)
05/07/1998CA2269670A1 A method for lowering plasma levels of lipoprotein(a)
04/1998
04/22/1998EP0644891B1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
04/15/1998EP0835121A1 COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT OF PLANTS OF GENUS $i(FILICIUM), AND USE OF SAID EXTRACT FOR STIMULATING GLYCOSAMINOGLYCAN SYNTHESIS
04/09/1998WO1998014194A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of anxiety
03/1998
03/17/1998US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
03/12/1998WO1998009935A1 Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
02/1998
02/17/1998US5719159 4-azasteroids with side-chain fluoroketones
01/1998
01/29/1998WO1998003207A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
01/29/1998CA2260253A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
01/28/1998EP0489779B1 Ophthalmic composition
01/22/1998WO1998002450A2 6,7-oxygenated steroids and uses related thereto
01/20/1998US5710259 Treating congestive heart failure
01/14/1998EP0719278B1 Androstenone derivative
12/1997
12/17/1997EP0719277B1 Androstenones
12/17/1997CN1036718C Method for preparing 19-demethyl steroid compound having thiocarbon chain at 11-beta position
12/16/1997US5698545 Angiostatic steroids and methods and compositions for controlling ocular hypertension
12/10/1997CN1167489A Novel estrenes for inducing hypothalamic effects
12/03/1997CN1166836A Novel androstanes with inducing hypothalamic effects
12/02/1997US5693770 Process for the manufacture of 3-amino-substituted glycosylated bile acids
11/1997
11/26/1997CN1036521C Process for preparing ester of organic acid with alcohol derivatives of 19-norsteroids and their salts
11/18/1997US5688780 Anticholesterol agents, cholesterol biosynthesis inhibition
11/13/1997WO1997042214A1 Androstene derivatives
11/04/1997US5683995 Androgen steroid hormones for hormone problems
10/1997
10/23/1997DE19615819A1 New 11beta-aryl-substituted 18-nor-steroid compounds
10/21/1997US5679666 Administering topically, systemically or intraocularly to a host steroids selected from pregnadien derivatives, hydroxyprogesterone and tetrahydrocortexolone
10/15/1997CN1161972A 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof
10/07/1997US5674861 Fluorinated steroids
08/1997
08/27/1997EP0567469B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES
08/26/1997US5661143 Inhibits (de)polymerization of tubulin to form cellular microtubes; anticarcinogenic,-tumor, inflammatory and wound healing agents; immunology; angiogenesis inhibitors
07/1997
07/30/1997EP0785943A1 Synthesis of 6-azaandrostenones
07/23/1997EP0784627A1 Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids
07/22/1997US5650526 Process for the preparation of an oxoetiocholenic acid
07/16/1997EP0783513A1 Novel estrenes for inducing hypothalamic effects
07/16/1997EP0783512A1 Novel androstanes for inducing hypothalamic effects
07/10/1997WO1997024365A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
07/10/1997CA2241728A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
07/09/1997EP0783001A1 Androstenones
06/1997
06/24/1997US5641877 Chemical intermediates
06/24/1997US5641765 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
06/18/1997EP0675897B1 New steroids
05/1997
05/27/1997US5633392 Estrenes for inducing hypothalamic effects
05/14/1997CN1034868C Preparing method for 6 alpha, 9 alpha-difluorido-progester-3,20-diones compound
04/1997
04/09/1997EP0766690A1 Process for the manufacture of 3-amino-substituted glycosylated bile acids
04/08/1997US5618806 Steroid 5alpha-reductase inhibitor; useful for treating benign prostatic hypertrophy, baldness, acne, vulguris, seborrhea, female hirsutism, and prostatic adenocarcinoma
03/1997
03/19/1997EP0763053A1 Steroid derivatives for treatment of 5 alpha reductase
02/1997
02/05/1997EP0756601A1 Compositions and methods for cell transformation
02/04/1997US5600047 Process for producing optically active olefin
01/1997
01/21/1997US5596110 Process for the preparation of 3 β, 14 β-dihydroxyethianaldehyde
01/16/1997WO1997001346A1 Cosmetic or pharmaceutical composition containing an extract of plants of genus filicium, and use of said extract for stimulating glycosaminoglycan synthesis
01/15/1997CN1140178A Use of new steroid compound for preparing medicaments
01/15/1997CN1140059A Process for preparing pharmaceutical composition contg. new steroid compounds
01/07/1997US5591733 Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
12/1996
12/17/1996US5585470 Process for the manufacture of 3-amino-substituted glycosylated bile acids
11/1996
11/13/1996CN1135758A Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
1 2 3 4 5 6 7 8 9 10 11